Literature DB >> 18516324

Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies.

S Vameşu1.   

Abstract

Angiogenesis, the formation of new blood vessels from a preexisting vascular bed, is a complex multistep process, which may also permit metastasis. To investigate how tumor angiogenesis correlates with tumor histologic type in breast carcinoma diagnosed on core biopsy, microvessels were counted (and graded the density of microvessels) within the initial invasive carcinomas of 155 patients. Using light microscopy, the number of microvessels was counted manually in a subjectively selected hot spot (in the most active areas of neovascularization per 400x field), and their values were separated as above or below median (low and high), without knowledge of the outcome in the patient or any other pertinent variable. When the mean values of MVD of the groups defined by histological type were compared, no significant difference was noted (P=0.060253). When tumors were classified as high or low MVD, based on a cut-off value (30.70175 microvessels per mm(2)), cases with high MVD were significantly more numerous. MVD did show a relationship with groups defined by tumor histological type (P=0.003101). Assessment of tumor angiogenesis may therefore prove valuable in selecting patients with early breast carcinoma for aggressive therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18516324

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  8 in total

1.  Fenofibrate enhances radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expression.

Authors:  Yangyang Ge; Jia Liu; Xi Yang; Hongcheng Zhu; Baixia Yang; Kuiling Zhao; Zhijun Wu; Guojian Cheng; Feng Wang; Feng Ni; Qin Ge; Yanguang Yang; Guomei Tai; Xinchen Sun; Jing Cai
Journal:  Tumour Biol       Date:  2014-07-30

2.  PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1α expression in MCF-7 breast cancer cells.

Authors:  Jun Du; Rui Xu; Zhenzhen Hu; Yinhui Tian; Yichao Zhu; Luo Gu; Lei Zhou
Journal:  PLoS One       Date:  2011-09-27       Impact factor: 3.240

3.  Expression of THOP1 and its relationship to prognosis in non-small cell lung cancer.

Authors:  Lei Qi; Shu-Hai Li; Li-Bo Si; Ming Lu; Hui Tian
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

4.  Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers.

Authors:  Efstathios Karathanasis; Leslie Chan; Lohitash Karumbaiah; Kathleen McNeeley; Carl J D'Orsi; Ananth V Annapragada; Ioannis Sechopoulos; Ravi V Bellamkonda
Journal:  PLoS One       Date:  2009-06-09       Impact factor: 3.240

5.  Melittin suppresses HIF-1α/VEGF expression through inhibition of ERK and mTOR/p70S6K pathway in human cervical carcinoma cells.

Authors:  Jae-Moon Shin; Yun-Jeong Jeong; Hyun-Ji Cho; Kwan-Kyu Park; Il-Kyung Chung; In-Kyu Lee; Jong-Young Kwak; Hyeun-Wook Chang; Cheorl-Ho Kim; Sung-Kwon Moon; Wun-Jae Kim; Yung-Hyun Choi; Young-Chae Chang
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

6.  HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).

Authors:  Ernestina Marianna De Francesco; Rosamaria Lappano; Maria Francesca Santolla; Stefania Marsico; Arnaldo Caruso; Marcello Maggiolini
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

7.  Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.

Authors:  Lei Qi; Feng Zhu; Shu-Hai Li; Li-Bo Si; Li-Kuan Hu; Hui Tian
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

8.  The state of the art in breast imaging using the Twente Photoacoustic Mammoscope: results from 31 measurements on malignancies.

Authors:  Michelle Heijblom; Daniele Piras; Frank M van den Engh; Margreet van der Schaaf; Joost M Klaase; Wiendelt Steenbergen; Srirang Manohar
Journal:  Eur Radiol       Date:  2016-03-05       Impact factor: 5.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.